echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > "ELife" breaks the "clear proof" that has not been available in the past decade and discovers new genetic factors for heart malformations

    "ELife" breaks the "clear proof" that has not been available in the past decade and discovers new genetic factors for heart malformations

    • Last Update: 2021-08-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the internationally renowned journal "eLife" officially published the joint research results of the National Children's Medical Center (Shanghai), the Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine, and the team of Professor Fu Qihua and the team of Researcher Zhang Zhen "SORBS2 is a genetic factor contributing to cardiac malformation of 4q deletion syndrome patients.


    Congenital heart disease is the most common birth defect and a major public health problem at this stage


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.